HCV New Drugs

This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.

Risk Of Developing Liver Cancer After HCV Treatment

▼

Showing posts with label ABT-450/r and ABT-072. Show all posts

Showing posts with label ABT-450/r and ABT-072. Show all posts

Tuesday, March 5, 2013

All-Oral Regimens Work in HCV

All-Oral Regimens Work in HCV By Michael Smith, North American Correspondent, MedPage Today Published: March 05, 2013 Reviewed by F. P...

Wednesday, May 2, 2012

ABT-450/r plus ABT-072 - Two Oral Drugs Clear HCV Without Interferon

From Medscape Medical News Two Oral Drugs Clear HCV Without Interferon Daniel M. Keller, PhD May 2, 2012 (Barcelona, Spain) — Twelve...

Friday, April 20, 2012

EASL-Oral HCV Combo Effective for Genotype One

Oral HCV Combo Effective for Genotype One By Michael Smith, North American Correspondent, MedPage Today Published: April 20, 2012 Revi...

Wednesday, April 4, 2012

EASL:Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C

April 4 EASL ABSTRACTS NOW READY TO VIEW Click Here . Public The abstracts will be available on the EASL website, http://www.easl.eu ...

View web version

Powered by Blogger.